Evaluating the Antitumor Activity of Nintedanib by Solid Lipid Nanoparticle Drug Delivery System: In vitro and In vivo. AJP [Internet]. 2026 Feb. 20 [cited 2026 Apr. 14];19(04). Available from: https://www.asiapharmaceutics.info/index.php/ajp/article/view/7190